Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Tracking

To track relevant regulatory trends across the nation, access our interactive map.
Go to Map

Regulatory Recap

A weekly e-newsletter informed by our Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers' comp. Explore our complete article repository below.

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.
Read More

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
Read More

New York Prepares to Launch New Claim Portal

Stakeholders will soon experience a streamlined digital process for managing claims.
Read More

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Read More

Side Effects: COVID-19-Related Healthcare and Pharmacy Trends Impacting Workers’ Comp

The pandemic has disrupted access to care, but the industry has implemented reactive measures
Read More
1 16 17 18 19 20 37

 Interactive Map

Interact with this map to explore how certain legislative trends are progressing across the country.
This Interactive Map represents legislation proposed from the most recent legislative cycle; in most states this is a two-year period. All Regulations are displayed for from their introduction date to present.
The content above is representative of topics Healthesystems proactively monitors and reports on. Topics are not exclusive to workers' comp and may include healthcare benefits, pharmacy and ancillary benefits, and professional licensing requirements. While not all topics are directly applicable to workers' comp claims, some have the potential to impact worker' comp in the future.
Back to Top
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle